Isan Chen
Overview
Isan Chen received an average of $2M in total compensation, including $361K in salary, at Mirati Therapeutics from 2013 to 2019.
2019Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
2018Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
2017Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
2016Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
2015Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
2013Mirati TherapeuticsExecutive Vice President and Chief Medical and Development Officer
Source: SEC filings on April 17, 2020, April 19, 2019, April 20, 2018, April 20, 2017, and April 17, 2014.
Related executives
We found five more executives who work or worked at Mirati Therapeutics.
Charles Baum
Mirati Therapeutics
Chief Executive Officer
James Christensen
Mirati Therapeutics
Chief Scientific Officer
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
Chris LeMasters
Mirati Therapeutics
Former Executive Vice President and Chief Business Officer
Mark Gergen
Mirati Therapeutics